Your browser doesn't support javascript.
Coeliac disease in the COVID-19 pandemic: does HLA have a protective effect?
Greco, N; Meacci, A; Mora, B; Vestri, A; Picarelli, A.
  • Greco N; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
  • Meacci A; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
  • Mora B; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
  • Vestri A; Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Rome, Italy.
  • Picarelli A; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Ann Med ; 54(1): 617-621, 2022 12.
Article in English | MEDLINE | ID: covidwho-1692413
ABSTRACT

BACKGROUND:

The coronavirus disease 2019 (COVID-19), an acute respiratory disease caused by a novel coronavirus (SARS-CoV-2), is emerging as a worldwide public health emergency. Several scientific contributions reported the potential relevance of human leukocyte antigen (HLA) polymorphism and susceptibility to viruses, such as SARS-CoV. In our study, we examined a population of coeliac subjects presenting the HLA haplotype DQ2 and/or DQ8. Our aim was to evaluate whether HLA DQ2 and/or DQ8 haplotype play a role in SARS-CoV-2-infection. The aim was also to evaluate the difficulty in following the gluten-free diet due to all the adversities produced by the pandemic, such as the food supply disruption, and the difficulties in managing the clinical follow-up.

METHODS:

191 consecutive coeliac patients completed a questionnaire on their current clinical status, psychological effects, and management of the gluten-free diet experienced during the COVID-19 pandemic and questions regarding possible SARS-CoV-2 infection.

RESULTS:

Out of the 191 patients who participated in the study, 42 were full-blown coeliac and 149 were in remission. From the answers provided, 84.8% of patients declared that they no longer consider themselves vulnerable to COVID-19 as they suffer from coeliac disease; 94.2% of patients did not encounter any difficulties in managing the gluten-free diet or in acquiring specific foods and 64.9% of patients in our study underwent diagnostic testing for SARS-CoV-2. Out of this number, 31.5% did so due to contacts with subjects affected by COVID-19, 26.6% for work related reasons, 11.3% due to flu-like symptoms and 30.6% for other reasons. Only 5.8% of the enrolled patients received a diagnosis of COVID-19. Out of all the patients in our population who were diagnosed with COVID-19, 94.8% developed no symptoms and none of them needed hospitalization or intensive care.

CONCLUSION:

The hypothesis that the HLADQ2 and/or DQ8 haplotype plays a protective role against SARS-CoV-2 infection, as against other viral infections, is intriguingly suggestive.KEY MESSAGESCOVID-19 as a public health emergency;SARS-CoV-2 and possible complications in coeliac disease;Role of HLA DQ2 and/or DQ8 in SARS-CoV-2 infection.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: HLA-DQ Antigens / Celiac Disease / COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Ann Med Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: 07853890.2022.2039955

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: HLA-DQ Antigens / Celiac Disease / COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Ann Med Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: 07853890.2022.2039955